1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Liver conditions
  5. Alcohol-use disorders

Rifaximin for preventing episodes of overt hepatic encephalopathy

Technology appraisal guidance [TA337] Published: 25 March 2015

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Review decision  
  • Review decision – June 2018  
  • Review decision paper PDF 426 KB 14 June 2018  
  • Matrix of stakeholders PDF 254 KB 14 June 2018